Citadel Advisors’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
|
|||||
|
2025
Q1 | $1.94M | Sell |
|
|||||
|
2024
Q4 | $5.64M | Sell |
|
|||||
|
2024
Q3 | $5.76M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $64.7K | Sell |
|
|||||
|
2023
Q4 | $363K | Sell |
|
|||||
|
2023
Q3 | $609K | Buy |
|
|||||
|
2023
Q2 | $622K | Buy |
|
|||||
|
2023
Q1 | $706K | Buy |
|
|||||
|
2022
Q4 | $206K | Sell |
|
|||||
|
2022
Q3 | $1.39M | Buy |
|
|||||
|
2022
Q2 | $357K | Sell |
|
|||||
|
2022
Q1 | $377K | Buy |
|
|||||
|
2021
Q4 | $765K | Buy |
|
|||||
|
2021
Q3 | $432K | Sell |
|
|||||
|
2021
Q2 | $503K | Sell |
|
|||||
|
2021
Q1 | $929K | Buy |
|
|||||
|
2020
Q4 | $350K | Buy |
|
|||||
|
2020
Q3 | $42K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $4.09M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $59K | Buy |
|